vs

Side-by-side financial comparison of Community Healthcare Trust Inc (CHCT) and ATRenew Inc. (RERE). Click either name above to swap in a different company.

ATRenew Inc. is the larger business by last-quarter revenue ($43.2M vs $30.9M, roughly 1.4× Community Healthcare Trust Inc). Community Healthcare Trust Inc runs the higher net margin — 46.6% vs 16.9%, a 29.7% gap on every dollar of revenue.

Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...

ATRenew Inc. operates a leading pre-owned consumer electronics transaction and servicing ecosystem primarily in China. Its core services include end-to-end device recycling, professional quality inspection, certified refurbishment, and resale of smartphones, laptops, tablets and other digital products, serving both individual consumers and enterprise clients across domestic and select Southeast Asian markets.

CHCT vs RERE — Head-to-Head

Bigger by revenue
RERE
RERE
1.4× larger
RERE
$43.2M
$30.9M
CHCT
Higher net margin
CHCT
CHCT
29.7% more per $
CHCT
46.6%
16.9%
RERE

Income Statement — Q4 FY2025 vs Q1 FY2023

Metric
CHCT
CHCT
RERE
RERE
Revenue
$30.9M
$43.2M
Net Profit
$14.4M
$7.3M
Gross Margin
Operating Margin
Net Margin
46.6%
16.9%
Revenue YoY
5.6%
Net Profit YoY
687.6%
EPS (diluted)
$0.52

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CHCT
CHCT
RERE
RERE
Q4 25
$30.9M
Q3 25
$31.1M
Q2 25
$29.1M
Q1 25
$30.1M
Q4 24
$29.3M
Q3 24
$29.6M
Q2 24
$27.5M
Q1 24
$29.3M
Net Profit
CHCT
CHCT
RERE
RERE
Q4 25
$14.4M
Q3 25
$1.6M
Q2 25
$-12.6M
Q1 25
$1.6M
Q4 24
$1.8M
Q3 24
$1.7M
Q2 24
$-10.4M
Q1 24
$3.7M
Net Margin
CHCT
CHCT
RERE
RERE
Q4 25
46.6%
Q3 25
5.3%
Q2 25
-43.2%
Q1 25
5.3%
Q4 24
6.3%
Q3 24
5.9%
Q2 24
-37.9%
Q1 24
12.5%
EPS (diluted)
CHCT
CHCT
RERE
RERE
Q4 25
$0.52
Q3 25
$0.03
Q2 25
$-0.50
Q1 25
$0.03
Q4 24
$0.04
Q3 24
$0.04
Q2 24
$-0.42
Q1 24
$0.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CHCT
CHCT
RERE
RERE
Cash + ST InvestmentsLiquidity on hand
$3.3M
$228.0M
Total DebtLower is stronger
$532.2M
Stockholders' EquityBook value
$429.4M
$557.1M
Total Assets
$990.8M
$722.9M
Debt / EquityLower = less leverage
1.24×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CHCT
CHCT
RERE
RERE
Q4 25
$3.3M
Q3 25
$3.4M
Q2 25
$4.9M
Q1 25
$2.3M
Q4 24
$4.4M
Q3 24
$2.8M
Q2 24
$734.0K
Q1 24
$3.8M
Total Debt
CHCT
CHCT
RERE
RERE
Q4 25
$532.2M
Q3 25
$530.1M
Q2 25
$500.1M
Q1 25
$496.0M
Q4 24
$486.0M
Q3 24
$473.7M
Q2 24
$457.6M
Q1 24
$442.3M
Stockholders' Equity
CHCT
CHCT
RERE
RERE
Q4 25
$429.4M
Q3 25
$426.8M
Q2 25
$437.8M
Q1 25
$461.3M
Q4 24
$476.0M
Q3 24
$477.2M
Q2 24
$497.8M
Q1 24
$511.6M
Total Assets
CHCT
CHCT
RERE
RERE
Q4 25
$990.8M
Q3 25
$987.3M
Q2 25
$966.3M
Q1 25
$985.1M
Q4 24
$992.6M
Q3 24
$981.8M
Q2 24
$983.2M
Q1 24
$982.7M
Debt / Equity
CHCT
CHCT
RERE
RERE
Q4 25
1.24×
Q3 25
1.24×
Q2 25
1.14×
Q1 25
1.08×
Q4 24
1.02×
Q3 24
0.99×
Q2 24
0.92×
Q1 24
0.86×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CHCT
CHCT
RERE
RERE
Operating Cash FlowLast quarter
$56.4M
Free Cash FlowOCF − Capex
$35.9M
FCF MarginFCF / Revenue
116.0%
Capex IntensityCapex / Revenue
66.3%
Cash ConversionOCF / Net Profit
3.91×
TTM Free Cash FlowTrailing 4 quarters
$62.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CHCT
CHCT
RERE
RERE
Q4 25
$56.4M
Q3 25
$12.7M
Q2 25
$13.8M
Q1 25
$14.4M
Q4 24
$58.9M
Q3 24
$13.8M
Q2 24
$16.7M
Q1 24
$12.6M
Free Cash Flow
CHCT
CHCT
RERE
RERE
Q4 25
$35.9M
Q3 25
$7.6M
Q2 25
$9.6M
Q1 25
$9.7M
Q4 24
$34.2M
Q3 24
$6.7M
Q2 24
$9.5M
Q1 24
$7.5M
FCF Margin
CHCT
CHCT
RERE
RERE
Q4 25
116.0%
Q3 25
24.6%
Q2 25
32.9%
Q1 25
32.3%
Q4 24
116.9%
Q3 24
22.5%
Q2 24
34.7%
Q1 24
25.7%
Capex Intensity
CHCT
CHCT
RERE
RERE
Q4 25
66.3%
Q3 25
16.3%
Q2 25
14.5%
Q1 25
15.6%
Q4 24
84.1%
Q3 24
24.2%
Q2 24
26.1%
Q1 24
17.4%
Cash Conversion
CHCT
CHCT
RERE
RERE
Q4 25
3.91×
Q3 25
7.76×
Q2 25
Q1 25
9.06×
Q4 24
32.14×
Q3 24
7.92×
Q2 24
Q1 24
3.45×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons